About this document
Core in Cup Tablets for Budesonide Release by vsaikishore11 is a document available to read on EtoBox.
This research article investigates the design, development, and in vivo evaluation of core in cup tablets of Budesonide for treating inflammatory bowel disease (IBD). The study demonstrates that the optimized core in cup tablet formulation significantly enhances the bioavailability of Budesonide compared to pure drug suspension, with a sixfold increase in AUC. The results indicate that this formulation technique is promising for effective chronotherapeutic management of IBD.
- Author
- vsaikishore11
- Language
- EN